18 Nov 2019 AFT Pharmaceuticals (ASX:AFP) has signed licensing agreements worth more than US$1billion for its Maxigesic pain relief medication. AFT Pharmaceuticals, 3.60, 3.60, 3.60, +0.00, +0.00%, 0.18K, 19/03. Cryosite Ltd, 0.072, 0.072, 0.072, +0.000, +0.00%, 0, 16/03. Fisher&Paykel Healthcare Following successful listing on the NZX and ASX stock exchanges in December 2015 AFT is looking to expand its Asian team to allow coverage of GPs and The latest AFT Pharmaceuticals news, articles, data and analysis from Australian View full company quote. ASX logo. Morningstar logo. No content found 4 Dec 2019 Dual-listed AFT Pharmaceuticals (ASX:AFP) is now expecting a lift in sales for its non-codeine painkiller Maxigesic. “In the 12 months after 8 Oct 2019 AFT Pharmaceuticals (NZX.AFT, ASX.AFP) and New Zealand medicinal cannabis company SETEK today announce they have signed a 2 Mar 2020 02 Mar 2020 - CIMIC Group (ASX:CIM) company CPB Contractors has been AFT Pharmaceuticals (ASX:AFP) on track to refinance loan.
25 Sep 2019 AFT Pharmaceuticals starts to license Maxigesic IV with deal in South Korea. 06 Nov 2018 - AFT Pharmaceuticals (ASX:AFP) has started the
27 Feb 2020 Is AFT PHARMACEUTICALS LIMITED (ASX:AFP) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical See AFT Pharmaceuticals's revenue, employees, and funding info on Owler, the world's 05 Dec 2019 - AFT Pharmaceuticals (ASX:AFP) has today welcomed NZX and ASX Listed Company; Dynamic growth phase; Multi national operation. Delivering efficient and effective inventory and logistics services to the AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. Its feature brands include 19 Nov 2019 AFT Pharmaceuticals Limited (ASX: AFP). AFP is engaged in developing, licencing and selling pharmaceutical products in Australasia and 5 Dec 2019 AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today welcomes AFT Pharmaceutical's Managing Director Dr Hartley Atkinson said the New 25 Nov 2019 AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company AFT. Primary exchange. NZX. Secondary exchange. ASX
18 Nov 2019 AFT Pharmaceuticals (ASX:AFP) has signed licensing agreements worth more than US$1billion for its Maxigesic pain relief medication.
17 Nov 2019 shares in AFT Pharmaceuticals rose after the company announced Shares in Imugene Limited (ASX: IMU) are trading 17.8 per higher at 5 5 Dec 2016 AFT. Primary exchange. NZX. Secondary exchange. ASX. Share price AFT Pharmaceuticals is a specialty pharmaceutical company that 27 Nov 2015 AFT Pharmaceuticals chief executive Dr Hartley Atkinson. Supporting Listing on the NZX and ASX is due on December 22. In the year to 26 Nov 2015 The issuer under this offer is AFT Pharmaceuticals Limited and the offerors are them on the NZX Main Board and ASX if there are interested 7 Apr 2016 AFT Pharmaceuticals has gone from the garage to the NZX main board, 19 years later and AFT is a NZ$300m company that is NZX and ASX
AFT Pharmaceuticals, 3.60, 3.60, 3.60, +0.00, +0.00%, 0.18K, 19/03. Cryosite Ltd, 0.072, 0.072, 0.072, +0.000, +0.00%, 0, 16/03. Fisher&Paykel Healthcare
5 Dec 2019 AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today welcomes AFT Pharmaceutical's Managing Director Dr Hartley Atkinson said the New 25 Nov 2019 AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company AFT. Primary exchange. NZX. Secondary exchange. ASX 18 Nov 2019 AFT Pharmaceuticals (ASX:AFP) has signed licensing agreements worth more than US$1billion for its Maxigesic pain relief medication. AFT Pharmaceuticals, 3.60, 3.60, 3.60, +0.00, +0.00%, 0.18K, 19/03. Cryosite Ltd, 0.072, 0.072, 0.072, +0.000, +0.00%, 0, 16/03. Fisher&Paykel Healthcare Following successful listing on the NZX and ASX stock exchanges in December 2015 AFT is looking to expand its Asian team to allow coverage of GPs and
AFT PHARMACEUTICALS LIMITED (AFP) is a company within the Health Care sector listed in the ASX indicies. Get the latest share prices for AFT
5 Dec 2019 AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today welcomes AFT Pharmaceutical's Managing Director Dr Hartley Atkinson said the New 25 Nov 2019 AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company AFT. Primary exchange. NZX. Secondary exchange. ASX 18 Nov 2019 AFT Pharmaceuticals (ASX:AFP) has signed licensing agreements worth more than US$1billion for its Maxigesic pain relief medication. AFT Pharmaceuticals, 3.60, 3.60, 3.60, +0.00, +0.00%, 0.18K, 19/03. Cryosite Ltd, 0.072, 0.072, 0.072, +0.000, +0.00%, 0, 16/03. Fisher&Paykel Healthcare Following successful listing on the NZX and ASX stock exchanges in December 2015 AFT is looking to expand its Asian team to allow coverage of GPs and The latest AFT Pharmaceuticals news, articles, data and analysis from Australian View full company quote. ASX logo. Morningstar logo. No content found 4 Dec 2019 Dual-listed AFT Pharmaceuticals (ASX:AFP) is now expecting a lift in sales for its non-codeine painkiller Maxigesic. “In the 12 months after